Laurent Pharmaceuticals
PrivateLast Round
Grant
Aug 29, 2023
Total Funding Raised
$10.31M
Company Overview
Laurent Pharmaceuticals operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Grant round in August 2023.
Laurent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops oral therapies for the treatment of severe inflammatory and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laurent Pharmaceuticals Comparables
Compare Laurent Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlgiPharma AS | 79% | |
| Enterprise Therapeutics | 77% | |
| SpliSense | 74% |
For institutional investors. Book with your work email.
Laurent Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 29, 2023 | ||||
| Grant | Dec 18, 2020 | ||||
| Debt | Dec 4, 2019 | ||||
| Early Funding | Oct 25, 2018 | ||||
| Grant | Mar 14, 2018 | ||||
Early Funding | Mar 17, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laurent Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Debt |
| AQC Capital | Early Funding |
| Anges Quebec | Early Funding |
| Aligo Innovation | Early Funding |
| Cystic Fibrosis Foundation | Grant |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Gouvernement du Québec | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 59% MoM, from 748 to 1.2K.
- Apr 16, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Laurent Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laurent Pharmaceuticals's valuation, stock price, and market status.
Is Laurent Pharmaceuticals a public or private company?
Laurent Pharmaceuticals is a private company.
What is the current stock price of Laurent Pharmaceuticals?
Laurent Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Laurent Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laurent Pharmaceuticals worth (valuation)?
Valuation information for Laurent Pharmaceuticals is not publicly available.
Can I buy Laurent Pharmaceuticals stock?
Laurent Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laurent Pharmaceuticals's last funding round?
Laurent Pharmaceuticals's most recent funding round was Grant on August 29, 2023.
Who are the main investors in Laurent Pharmaceuticals?
Key investors in Laurent Pharmaceuticals include AQC Capital, Anges Quebec, Keiretsu Forum Mid-Atlantic.
Will Laurent Pharmaceuticals IPO soon?
No public IPO plans have been announced for Laurent Pharmaceuticals.
How can I track Laurent Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Laurent Pharmaceuticals's shares on secondary markets.